Previous Article | Next Article ![]()
Journal of Clinical Microbiology, June 2004, p. 2701-2706, Vol. 42, No. 6
0095-1137/04/$08.00+0 DOI: 10.1128/JCM.42.6.2701-2706.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Department of Microbiology, School of Medicine, Marmara University, Istanbul, Turkey,1 Enveloppe Bactérienne, Perméabilité et Antibiotiques, EA 2197, IFR48, Faculté de Médecine, Université de la Mediterranée, Marseille,2 Service de Bactériologie-Virologie, Hôpital de Bicêtre, Faculté de Médecine Paris Sud, Université Paris XI, Le Kremlin-Bicêtre, France3
Received 29 October 2003/ Returned for modification 7 January 2004/ Accepted 13 February 2004
The prevalence of active drug efflux pump and porin alterations was investigated in Turkish nosocomial strains of Klebsiella pneumoniae exhibiting a multidrug-resistant phenotype. MICs of various antibiotics, including quinolones, chloramphenicol, tetracycline, and ß-lactams, for those strains were determined either with or without the efflux pump inhibitor phenylalanine arginine ß-naphthylamide (PAßN). Thirty-nine percent of the strains exhibited a PAßN-modulated resistance for quinolones, chloramphenicol, and tetracycline. In these strains, a significant increase of chloramphenicol accumulation was gained in the presence of the efflux pump inhibitor PAßN or with the energy uncoupler carbonyl cyanide m-chlorophenylhydrazone. Moreover, high-level expression of the membrane fusion protein AcrA, which was immunodetected in most of those isolates, suggests that the AcrAB/TolC efflux machinery contributed to their antibiotic resistance. Studies of K. pneumoniae porins indicated that the majority of the strains, including extended-spectrum ß-lactamase producers and efflux-positive ones, presented an alteration in their sorbitol-sensitive porin (OmpK35) expression. This is the first report showing the prominent role of active drug efflux in the antibiotic resistance of nosocomial K. pneumoniae strains from Turkey.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|